Next Quarterly Earnings
Thursday, November 12, 2026
CW 46
Pre-Market
In 77 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
HLB
HLB is a South Korean biopharmaceutical company focused on developing innovative cancer therapies. Its lead candidate is the targeted drug rivoceranib for treating solid tumours. Through affiliated companies, the group is also active in other biotechnology and medical-device ventures.
Frequently asked questions
When will HLB report its next quarterly earnings?
HLB is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did HLB last report quarterly earnings?
HLB last reported quarterly earnings on 11/11/2025 (Q3 2025).
How do I add the HLB earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Company Information
Name
HLB
Country
🇰🇷
More Financial Information